Sign in Subscribe
COVID-19

COVID-19 Research Reveals Complex Interactions at Mucosal Barriers

Strategic Insights

— 2 min read

Research conducted by the Medical University of Innsbruck has uncovered complex interactions at mucosal barriers in SARS-CoV-2 infection, providing new insights into the COVID-19 pandemic. The study investigated primary human bronchial epithelial cells infected with the Delta variant, revealing changes in the small RNA transcriptome and the expression of specific microRNAs, PIWI-interacting RNAs, small nucleolar RNAs, vault RNAs, Y RNAs, and long intergenic non-coding RNAs. These findings highlight distinct molecular responses in SARS-CoV-2-infected cells, revealing specific genes and non-coding RNAs involved in viral replication, immune response, and apoptosis.

Key Takeaways:

  • The study found that SARS-CoV-2 infection initiates complex interactions at mucosal barriers, with changes in the small RNA transcriptome and the expression of specific microRNAs, PIWI-interacting RNAs, small nucleolar RNAs, vault RNAs, Y RNAs, and long intergenic non-coding RNAs.
  • The research identified differential expression of 7SL, U2, and RPPH1 RNAs, as well as miR-155-5p and miR-27a-5p, which are involved in antiviral signaling.
  • The study found that the ribosomal protein RPSA has recently been reported to serve as a viral surface receptor promoting pro-inflammatory cytokine signaling.
  • The research observed a significantly lower expression of the protein-coding genes CXCL10, IFIT2, and ZC3HAV1 after Omicron BA.2 variant infection compared to Delta variant infection.
  • The study identified miR-155-5p and 5'-tRFGlu(TTC) as potential biomarkers for disease severity, with changes in their expression similar between Delta and Omicron variants.
  • The research concluded that the findings highlight distinct molecular responses in SARS-CoV-2-infected cells, revealing specific genes and non-coding RNAs involved in viral replication, immune response, and apoptosis.
  • The study involved a collaboration between researchers from the Medical University of Innsbruck, including Glory Ranches, Hubert Hackl, Viktoria Zaderer, Melanie Ploner, Wilfried Posch, Doris Wilflingseder, Kai Kummer, and Alexander Huttenhofer.

Statistics:

  • 2025: The year the research was conducted.
  • 36(2): The volume and issue number of the journal where the study was published (Molecular Therapy: Nucleic Acids).
  • 102559: The article number of the study in the journal (Molecular Therapy: Nucleic Acids).
  • 10.1016/j.omtn.2025.102559: The DOI of the study.
  • 159: The page number of the news report in Medical Letter on the CDC & FDA.

Sources:

  • Differentially expressed ncRNAs as key regulators in infection of human bronchial epithelial cells by the SARS-CoV-2 Delta variant. Molecular Therapy: Nucleic Acids, 2025,36(2):102559. (Molecular Therapy: Nucleic Acids - http://www.cell.com/molecular-therapy-family/nucleic-acids/latest-content).
  • Medical Letter on the CDC & FDA. June 22, 2025; p 159.

Read more